Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

51.47
Delayed Data
As of Sep 23
 +0.24 / +0.47%
Today’s Change
48.01
Today|||52-Week Range
66.55
-21.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line140.9M502.5M633.6M246.0M
 
 
 
 
 
Depreciation330.6M339.1M305.3M312.9M
 
 
 
 
 
Total Other Cash Flow883.6M188.5M293.3M380.2M
 
 
 
 
 
Funds From Operations1.7B1.4B1.2B990.2M
 
 
 
 
 
Funds From/For Other Operating Expenses489.0M-267.7M-196.2M16.2M
 
 
 
 
 
Net Cash Flow - Operating Activities1.2B1.6B1.4B974.0M
 
 
 
 
 
 
InvestingCapital Expenditures-178.4M-250.2M-172.2M-176.7M
 
 
 
 
 
Fixed Asset Disposal83.9M18.2M2.0M37.2M
 
 
 
 
 
Net Assets From Acquisitions -127.3M-19.2M-2.2B-86.1M
 
 
 
 
 
Other Investing - Uses-46.7M-64.4M-29.0M-8.2M
 
 
 
 
 
Other Investing - Sources0.000.0018.0M-2.9M
 
 
 
Net Cash Flow Investing-268.4M-315.6M-2.4B-236.6M
 
 
 
 
 
 
FinancingShort Term Borrowings-799.4M-1.5B38.0M723.9M
 
 
 
 
 
Long Term Borrowings56.6M-39.7M0.000.00
 
 
 
Long Term Debt Reduction-72.9M-54.7M-44.0M-1.2M
 
 
 
 
 
Net Proceeds Stock Sale87.3M6.6B671.6M9.9M
 
 
 
 
 
Common Preferred Redeemed-11.4M-1.9M0.000.00
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-300.6M-293.6M-367.3M-379.5M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing13.9M14.7M31.0M71.5M
 
 
 
 
 
Net Cash Flow - Financing-1.1B4.7B267.2M281.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-7.9M-19.2M-208.2M2.1M
 
 
 
 
 
 
Net Change In Cash-161.4M6.0B-774.7M1.0B